{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:38:14Z","timestamp":1790642294040,"version":"4.1.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","award":["305169"],"award-info":[{"award-number":["305169"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","award":["305169"],"award-info":[{"award-number":["305169"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","award":["305169"],"award-info":[{"award-number":["305169"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","award":["305169"],"award-info":[{"award-number":["305169"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Preeclampsia remains a leading cause of maternal and perinatal morbidity and mortality. Accurate prediction of preeclampsia risk would enable more effective, risk-based prenatal care pathways. Current risk assessment algorithms depend on clinical risk factors largely unavailable for first-time pregnant women. Delivering accurate preeclampsia risk assessment to this cohort of women, therefore requires for novel biomarkers. Here, we evaluated the relevance of metabolite biomarker candidates for their selection into a prototype rapid, quantitative Liquid Chromatography-tandem Mass Spectrometry (LC-MS\/MS) based clinical screening assay. First, a library of targeted LC-MS\/MS assays for metabolite biomarker candidates was developed, using a medium-throughput translational metabolomics workflow, to verify biomarker potential in the Screening-for-Pregnancy-Endpoints (SCOPE, European branch) study. A variable pre-selection step was followed by the development of multivariable prediction models for pre-defined clinical use cases, i.e., prediction of preterm preeclampsia risk and of any preeclampsia risk. Within a large set of metabolite biomarker candidates, we confirmed the potential of dilinoleoyl-glycerol and heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine to effectively complement Placental Growth Factor, an established preeclampsia biomarker, for the prediction of preeclampsia risk in first-time pregnancies without overt risk factors. These metabolites will be considered for integration in a prototype rapid, quantitative LC-MS\/MS assay, and subsequent validation in an independent cohort.<\/jats:p>","DOI":"10.1371\/journal.pone.0244369","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T18:48:08Z","timestamp":1609181288000},"page":"e0244369","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prediction of preeclampsia risk in first time pregnant women: Metabolite biomarkers for a clinical test"],"prefix":"10.1371","volume":"15","author":[{"given":"Louise C.","family":"Kenny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6247-9438","authenticated-orcid":true,"given":"Gr\u00e9goire","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Poston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A. B.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus P.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie W.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison E.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8734-7335","authenticated-orcid":true,"given":"Robin","family":"Tuytten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Screening for Pregnancy Endpoints Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"issue":"10022","key":"pone.0244369.ref001","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"BWJ Mol","year":"2016","journal-title":"Lancet"},{"key":"pone.0244369.ref002","volume-title":"Hypertension in pregnancy: diagnosis and management","author":"National Institute for Health and Care Excellence","year":"2019"},{"issue":"1","key":"pone.0244369.ref003","first-page":"e1","article-title":"ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia","volume":"133","author":"American College of Obstetricians and Gynecologists","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"7","key":"pone.0244369.ref004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"DL Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0244369.ref005","volume-title":"Antenatal care for uncomplicated pregnancies","author":"National Institute for Health and Care Excellence","year":"2008"},{"issue":"1","key":"pone.0244369.ref006","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/AOG.0000000000002709","article-title":"ACOG Committee Opinion No. 743 Summary","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"5","key":"pone.0244369.ref007","first-page":"1122","article-title":"merican College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Hypertension in Pregnancy. Obstet Gynecol"},{"issue":"6","key":"pone.0244369.ref008","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"N O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"pone.0244369.ref009","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/1471-0528.13334","article-title":"Quality of first trimester risk prediction models for pre-eclampsia: A systematic review","volume":"122","author":"VB Brunelli","year":"2015","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"6","key":"pone.0244369.ref010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000490385","article-title":"External Validation and Clinical Usefulness of First Trimester Prediction Models for the Risk of Preeclampsia: A Prospective Cohort Study","volume":"45","author":"LJE Meertens","year":"2019","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"pone.0244369.ref011","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/10641955.2019.1584210","article-title":"External validation of prognostic models for preeclampsia in a Dutch multicenter prospective cohort","volume":"38","author":"M Lamain-de Ruiter","year":"2019","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"pone.0244369.ref012","doi-asserted-by":"crossref","first-page":"62.e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"D Wright","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"pone.0244369.ref013","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/1471-0528.15664","article-title":"Evaluation of a simple risk score to predict preterm pre-eclampsia using maternal characteristics: a prospective cohort study","volume":"126","author":"U Sovio","year":"2019","journal-title":"BJOG"},{"key":"pone.0244369.ref014","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.preghy.2019.08.133","article-title":"Screening performance of a simple risk score using maternal characteristics for the prediction of preterm preeclampsia in a healthy nulliparous population","volume":"17","author":"J Myers","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"pone.0244369.ref015","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"High Risk of Pre-eclampsia Identification Group. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"E Bartsch","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"pone.0244369.ref016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/HYPERTENSIONAHA.112.191213","article-title":"Low placental growth factor across pregnancy identifies a subset of women with preterm Preeclampsia type 1 versus type 2 preeclampsia?","volume":"60","author":"RW Powers","year":"2012","journal-title":"Hypertension"},{"issue":"5","key":"pone.0244369.ref017","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.119.13360","article-title":"Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women","volume":"74","author":"S Agrawal","year":"2019","journal-title":"Hypertension"},{"issue":"S1","key":"pone.0244369.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre\u2010eclampsia: A pragmatic guide for first\u2010trimester screening and prevention","volume":"145","author":"LC Poon","year":"2019","journal-title":"Int J Gynecol Obstet"},{"issue":"11","key":"pone.0244369.ref019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11906-015-0595-4","article-title":"Preeclampsia: Syndrome or Disease?","volume":"17","author":"L Myatt","year":"2015","journal-title":"Curr Hypertens Rep"},{"issue":"9741","key":"pone.0244369.ref020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"EA Steegers","year":"2010","journal-title":"Lancet"},{"issue":"1\u20132","key":"pone.0244369.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2013.05.003","article-title":"If we know so much about preeclampsia, why haven\u2019t we cured the disease?","volume":"99","author":"JM Roberts","year":"2013","journal-title":"J Reprod Immunol"},{"issue":"23","key":"pone.0244369.ref022","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa025225","article-title":"Screening newborns for inborn errors of metabolism by tandem mass spectrometry","volume":"348","author":"B Wilcken","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0244369.ref023","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.110.157297","article-title":"Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers","volume":"56","author":"LC Kenny","year":"2010","journal-title":"Hypertension"},{"issue":"1","key":"pone.0244369.ref024","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2393-13-226","article-title":"A multi-centre phase IIa clinical study of predictive testing for preeclampsia: improved pregnancy outcomes via early detection (IMPROvED)","volume":"13","author":"K Navaratnam","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"pone.0244369.ref025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive Disorders of Pregnancy","volume":"72","author":"MA Brown","year":"2018","journal-title":"Hypertension"},{"key":"pone.0244369.ref026","doi-asserted-by":"crossref","first-page":"d1875","DOI":"10.1136\/bmj.d1875","article-title":"Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort","volume":"342","author":"RA North","year":"2011","journal-title":"BMJ"},{"issue":"13","key":"pone.0244369.ref027","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1471-0528.2010.02737.x","article-title":"Risk factors for small-for-gestational-age infants by customised birthweight centiles: Data from an international prospective cohort study","volume":"117","author":"LME McCowan","year":"2010","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"3","key":"pone.0244369.ref028","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/HYPERTENSIONAHA.114.03578","article-title":"Early Pregnancy Prediction of Preeclampsia in Nulliparous Women, Combining Clinical Risk and Biomarkers: The Screening for Pregnancy Endpoints (SCOPE) International Cohort Study","volume":"64","author":"LC Kenny","year":"2014","journal-title":"Hypertension"},{"key":"pone.0244369.ref029","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2018"},{"issue":"4","key":"pone.0244369.ref030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"MH Zweig","year":"1993","journal-title":"Clin Chem"},{"issue":"16","key":"pone.0244369.ref031","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"JD Storey","year":"2003","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"pone.0244369.ref032","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cem.2609","article-title":"Partial least squares discriminant analysis: taking the magic away","volume":"28","author":"RG Brereton","year":"2014","journal-title":"J Chemom"},{"key":"pone.0244369.ref033","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4612-0711-5","volume-title":"A Probabilistic Theory of Pattern Recognition","author":"L Devroye","year":"1996"},{"key":"pone.0244369.ref034","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijcard.2015.07.039","article-title":"Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure","volume":"199","author":"E Gayat","year":"2015","journal-title":"Int J Cardiol"},{"issue":"12","key":"pone.0244369.ref035","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/jcp.2008.055236","article-title":"The placenta in pre-eclampsia and intrauterine growth restriction","volume":"61","author":"DJ Roberts","year":"2008","journal-title":"J Clin Pathol"},{"key":"pone.0244369.ref036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The Two Stage Model of Preeclampsia: Variations on the Theme","volume":"30","author":"JM Roberts","year":"2009","journal-title":"Placenta"},{"issue":"1","key":"pone.0244369.ref037","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers","volume":"33","author":"R Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"pone.0244369.ref038","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41512-017-0017-y","article-title":"A novel method for interrogating receiver operating characteristic curves for assessing prognostic tests","volume":"1","author":"G Thomas","year":"2017","journal-title":"Diagnostic Progn Res"},{"issue":"4","key":"pone.0244369.ref039","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"DL Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"pone.0244369.ref040","doi-asserted-by":"crossref","first-page":"b2255","DOI":"10.1136\/bmj.b2255","article-title":"Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study","volume":"338","author":"S Hernandez-Diaz","year":"2009","journal-title":"BMJ"},{"key":"pone.0244369.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"SJ Benton","year":"2016","journal-title":"Placenta"},{"issue":"3","key":"pone.0244369.ref042","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10456-008-9114-4","article-title":"The discovery of the placental growth factor and its role in angiogenesis: a historical review","volume":"11","author":"D Ribatti","year":"2008","journal-title":"Angiogenesis"},{"issue":"7","key":"pone.0244369.ref043","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating Angiogenic Factors and the Risk of Preeclampsia","volume":"350","author":"RJ Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0244369.ref044","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"K Chau","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"7","key":"pone.0244369.ref045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/metabo9070126","article-title":"The Search for Clinically Useful Biomarkers of Complex Disease: A Data Analysis Perspective","volume":"9","author":"EC Considine","year":"2019","journal-title":"Metabolites"},{"issue":"3","key":"pone.0244369.ref046","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000338470","article-title":"A Competing Risks Model in Early Screening for Preeclampsia","volume":"32","author":"D Wright","year":"2012","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"pone.0244369.ref047","first-page":"1","article-title":"Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia","volume":"10","author":"SM Lee","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0244369.ref048","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41372-018-0275-8","article-title":"Second trimester inflammatory and metabolic markers in women delivering preterm with and without preeclampsia","volume":"39","author":"KM Ross","year":"2019","journal-title":"J Perinatol"},{"issue":"1","key":"pone.0244369.ref049","first-page":"1","article-title":"Comprehensive metabolomic analysis of first-trimester serum identifies biomarkers of early-onset hypertensive disorder of pregnancy","volume":"10","author":"H Kyozuka","journal-title":"Sci Rep. 2020"},{"issue":"1","key":"pone.0244369.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15882-9","article-title":"Integrated Proteomic and Metabolomic prediction of Term Preeclampsia","volume":"7","author":"R Bahado-Singh","year":"2017","journal-title":"Sci Rep"},{"issue":"13","key":"pone.0244369.ref051","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.121164498","article-title":"Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance","volume":"98","author":"JK Kim","year":"2001","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"pone.0244369.ref052","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1172\/JCI30565","article-title":"Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance","volume":"117","author":"L Liu","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"pone.0244369.ref053","doi-asserted-by":"crossref","first-page":"327.e1","DOI":"10.1016\/j.ajog.2011.02.024","article-title":"Maternal insulin resistance and preeclampsia","volume":"204","author":"JC Hauth","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"pone.0244369.ref054","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nm0410-400","article-title":"Diacylglycerol-mediated insulin resistance","volume":"16","author":"DM Erion","year":"2010","journal-title":"Nat Med"},{"issue":"8","key":"pone.0244369.ref055","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1194\/jlr.M057562","article-title":"Plasma diacylglycerol composition is a biomarker of metabolic syndrome onset in rhesus monkeys","volume":"56","author":"MA Polewski","year":"2015","journal-title":"J Lipid Res"},{"issue":"1","key":"pone.0244369.ref056","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajog.2005.07.049","article-title":"Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia","volume":"195","author":"RB Ness","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"pone.0244369.ref057","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/REP-10-0088","article-title":"Obesity, insulin resistance, and pregnancy outcome","volume":"140","author":"PM Catalano","year":"2010","journal-title":"Reproduction"},{"key":"pone.0244369.ref058","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jri.2015.01.009","article-title":"Endothelial dysfunction and metabolic syndrome in preeclampsia: An alternative viewpoint","volume":"108","author":"M Scioscia","year":"2015","journal-title":"J Reprod Immunol"},{"issue":"7","key":"pone.0244369.ref059","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: Pharmacology, physiology, and pathophysiology","volume":"55","author":"YC Yung","year":"2014","journal-title":"J Lipid Res"},{"issue":"9","key":"pone.0244369.ref060","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/j.bmc.2009.03.030","article-title":"Autotaxin structure\u2013activity relationships revealed through lysophosphatidylcholine analogs","volume":"17","author":"EJ North","year":"2009","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"pone.0244369.ref061","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1152\/physiol.00006.2013","article-title":"Elucidating Immune Mechanisms Causing Hypertension During Pregnancy","volume":"28","author":"B LaMarca","year":"2013","journal-title":"Physiology"},{"issue":"5","key":"pone.0244369.ref062","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.HYP.0000143849.67254.ca","article-title":"Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia","volume":"44","author":"DJ Freeman","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"pone.0244369.ref063","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/10641950802601237","article-title":"Preeclampsia is Associated with Lower Percentages of Regulatory T Cells in Maternal Blood","volume":"28","author":"JR Prins","year":"2009","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"pone.0244369.ref064","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1600-0897.2010.00831.x","article-title":"Immunology of Pre-Eclampsia","volume":"63","author":"CWG Redman","year":"2010","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"pone.0244369.ref065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aji.13176","article-title":"Placental expression of lysophosphatidic acid receptors in normal pregnancy and preeclampsia","volume":"82","author":"T Fujii","year":"2019","journal-title":"Am J Reprod Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:03:41Z","timestamp":1697454221000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244369"}},"subtitle":[],"editor":[{"given":"Frank T.","family":"Spradley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":65,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0244369","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,28]]}}}